Ann: Change in substantial holding, page-37

I've just done a research report search:
- Macquarie are covering the stock but do not report a target price (they are conflicted, given MacCap are advising MIN on the ALB deal)
- Bell Potter - Recommendation Buy - target price is $19.55 (at 23 August 2019)
- Morningstar Equity Research target price (which they call 'fair value&apos is $20.00 (at 23 August 2019)
- Morgan Stanley - 'Stock Rating' Overweight - target price is $18.00 (at 22 August 2019)

Note that the Morningstar report is not the Morningstar valuation we see on our Westpac/Commsec apps - that one is quantitative (based on mathematical models looking at trading activity). This one is far more considered and is very detailed in its analysis.

On the earnings call on 22 Aug, CE said the following re Wogdina deal:
- 'We're looking to get closed off with Albemarle in the very short term'
- 'They give us a cheque for $820m. That all happens 5 days after we get the final approval that we're waiting on for authorities. We think that's going to be well before Christmas. Everything we've had out of those approvals have been very positive, and so they should be.'

Hopefully some nice near-term price action on the back of the Wodgina money coming in.

Cheers
CB